miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating nF-κB pathway

Biochemical and Biophysical Research Communications

Volumn 457, Issue 3, 2015, Pages 370-377

  Zhao, Liang ^a   Zhang, Yubao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Hepatocellular carcinoma; MiR 342 3p; NF B signaling

Indexed keywords

CYCLIN D1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE EPSILON; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; MICRORNA 342 3P; MYC PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG; I KAPPA B KINASE; MIRN342 MICRORNA, HUMAN; RELA PROTEIN, HUMAN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAB2 PROTEIN, HUMAN; TAB3 PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HCT116 CELL LINE; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MTT ASSAY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HEP G2 CELLS; HUMANS; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 84922713816     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.119     Document Type: Article

References (39)

1. C.M. Wong, I.O. Ng, Molecular pathogenesis of hepatocellular carcinoma, Liver Int. 28 (2008) 160-174.
2. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, B.P. Bell, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J. Hepatol. 45 (2006) 529-538.
3. A.J. Sanyal, S.K. Yoon, R. Lencioni, The etiology of hepatocellular carcinoma and consequences for treatment, Oncologist 15 (Suppl. 4) (2010) 14-22.
4. E.V. Makeyev, T. Maniatis, Multilevel regulation of gene expression by microRNAs, Science 319 (2008) 1789-1790.
5. N. Bushati, S.M. Cohen, microRNA functions, Annu Rev. Cell. Dev. Biol. 23 (2007) 175-205.
6. I. Alvarez-Garcia, E.A. Miska, MicroRNA functions in animal development and human disease, Development 132 (2005) 4653-4662.
7. A.K. Leung, P.A. Sharp, MicroRNA functions in stress responses, Mol. Cell. 40 (2010) 205-215.
8. B. Yan, L.H. Zhao, J.T. Guo, J.L. Zhao, miR-429 regulation of osmotic stress transcription factor 1 (OSTF1) in tilapia during osmotic stress, Biochem. Biophys. Res. Commun. 426 (2012) 294-298.
9. J.T. DeSano, L. Xu, MicroRNA regulation of cancer stem cells and therapeutic implications, AAPS J. 11 (2009) 682-692.
10. A. Esquela-Kerscher, F.J. Slack, Oncomirs - microRNAs with a role in cancer, Nat. Rev. Cancer 6 (2006) 259-269.
11. W. Zhu, J. He, D. Chen, B. Zhang, L. Xu, H. Ma, X. Liu, Y. Zhang, H. Le, Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer, PLoS One 9 (2014) e87780.
12. N.A. Schultz, C. Dehlendorff, B.V. Jensen, J.K. Bjerregaard, K.R. Nielsen, S.E. Bojesen, D. Calatayud, S.E. Nielsen, M. Yilmaz, N.H. Hollander, K.K. Andersen, J.S. Johansen, MicroRNA biomarkers in whole blood for detection of pancreatic cancer, JAMA 311 (2014) 392-404.
13. F.E. Ahmed, N.C. Ahmed, P.W. Vos, C. Bonnerup, J.N. Atkins, M. Casey, G.J. Nuovo, W. Naziri, J.E. Wiley, H. Mota, R.R. Allison, Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle, Cancer Genomics Proteomics 10 (2013) 93-113.
14. J. Li, L. Du, Y. Yang, C. Wang, H. Liu, L. Wang, X. Zhang, W. Li, G. Zheng, Z. Dong, MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2, Cancer Lett. 329 (2013) 84-90.
15. Y. Wang, M. Li, W. Zang, Y. Ma, N. Wang, P. Li, T. Wang, G. Zhao, MiR-429 upregulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma, Cell. Oncol. (Dordr) 36 (2013) 385-394.
16. J. Krutzfeldt, N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel, Silencing of microRNAs in vivo with 'antagomirs', Nature 438 (2005) 685-689.
17. D.M. Cittelly, P.M. Das, N.S. Spoelstra, S.M. Edgerton, J.K. Richer, A.D. Thor, F.E. Jones, Downregulation of miR-342 is associated with tamoxifen resistant breast tumors, Mol. Cancer 9 (2010) 317.
18. J. Montag, R. Hitt, L. Opitz, W.J. Schulz-Schaeffer, G. Hunsmann, D. Motzkus, Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease, Mol. Neurodegener. 4 (2009) 36.
19. Q. Li, N. Zhang, Z. Jia, X. Le, B. Dai, D. Wei, S. Huang, D. Tan, K. Xie, Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression, Cancer Res. 69 (2009) 3501-3509.
20. D.W. Chan, S.Y. Yu, P.M. Chiu, K.M. Yao, V.W. Liu, A.N. Cheung, H.Y. Ngan, Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis, J. Pathol. 215 (2008) 245-252.
21. X.R. Li, H.J. Chu, T. Lv, L. Wang, S.F. Kong, S.Z. Dai, miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer, FEBS Lett. 588 (2014) 3298-3307.
22. B. Sun, M. Karin, NF-kappaB signaling, liver disease and hepatoprotective agents, Oncogene 27 (2008) 6228-6244.
23. T. Danford, A. Rolfe, D. Gifford, GSE: a comprehensive database system for the representation, retrieval, and analysis of microarray data, Pac. Symp. Biocomput. (2008) 539-550.
24. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, T.R. Golub, MicroRNA expression profiles classify human cancers, Nature 435 (2005) 834-838.
25. H.L. Pahl, Activators and target genes of Rel/NF-kappaB transcription factors, Oncogene 18 (1999) 6853-6866.
26. T.D. Gilmore, Introduction to NF-kappaB: players, pathways, perspectives, Oncogene 25 (2006) 6680-6684.
27. A. Hoffmann, G. Natoli, G. Ghosh, Transcriptional regulation via the NF-kappaB signaling module, Oncogene 25 (2006) 6706-6716.
28. N.D. Perkins, Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway, Oncogene 25 (2006) 6717-6730.
29. A. Kanayama, R.B. Seth, L. Sun, C.K. Ea, M. Hong, A. Shaito, Y.H. Chiu, L. Deng, Z.J. Chen, TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains, Mol. Cell. 15 (2004) 535-548.
30. T. Motokura, T. Bloom, H.G. Kim, H. Juppner, J.V. Ruderman, H.M. Kronenberg, A. Arnold, A novel cyclin encoded by a bcl1-linked candidate oncogene, Nature 350 (1991) 512-515.
31. D.J. Lew, V. Dulic, S.I. Reed, Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast, Cell 66 (1991) 1197-1206.
32. S.N. Finver, K. Nishikura, L.R. Finger, F.G. Haluska, J. Finan, P.C. Nowell, C.M. Croce, Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered, Proc. Natl. Acad. Sci. U S A 85 (1988) 3052-3056.
33. S. Begley, DNA Pioneer James Watson takes aim at Cancer Establishments, Reuters, 2013.
34. J. Zhang, Y.B. Kou, J.S. Zhu, W.X. Chen, S. Li, Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-kappaB pathway in vitro and in vivo, Int. J. Oncol. 44 (2014) 1268-1276.
35. M.L. Sheng, G.L. Xu, C.H. Zhang, W.D. Jia, W.H. Ren, W.B. Liu, T. Zhou, Y.C. Wang, Z.L. Lu, W.F. Liu, X.Z. Dong, X.J. Wang, Y. Lv, Aberrant estrogen receptor alpha expression correlates with hepatocellular carcinoma metastasis and its mechanisms, Hepatogastroenterology 61 (2014) 146-150.
36. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, Y. Ben-Neriah, NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Nature 431 (2004) 461-466.
37. P. Muriel, NF-kappaB in liver diseases: a target for drug therapy, J. Appl. Toxicol. 29 (2009) 91-100.
38. X. Ma, L.E. Becker Buscaglia, J.R. Barker, Y. Li, MicroRNAs in NF-kappaB signaling, J. Mol. Cell. Biol. 3 (2011) 159-166.
39. T.D. Gilmore, M. Herscovitch, Inhibitors of NF-kappaB signaling: 785 and counting, Oncogene 25 (2006) 6887-6899.